KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Capital Employed (2016 - 2025)

Evolent Health has reported Return on Capital Employed over the past 11 years, most recently at 0.23% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.23% for Q4 2025, down 21.0% from a year ago — trailing twelve months through Dec 2025 was 0.23% (down 21.0% YoY), and the annual figure for FY2025 was 0.22%, down 20.0%.
  • Return on Capital Employed for Q4 2025 was 0.23% at Evolent Health, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Capital Employed for EVH hit a ceiling of 0.0% in Q4 2022 and a floor of 0.27% in Q1 2021.
  • Median Return on Capital Employed over the past 5 years was 0.02% (2023), compared with a mean of 0.04%.
  • Biggest five-year swings in Return on Capital Employed: increased 25bps in 2022 and later decreased -21bps in 2025.
  • Evolent Health's Return on Capital Employed stood at 0.05% in 2021, then soared by 106bps to 0.0% in 2022, then crashed by -1424bps to 0.04% in 2023, then soared by 37bps to 0.02% in 2024, then crashed by -922bps to 0.23% in 2025.
  • The last three reported values for Return on Capital Employed were 0.23% (Q4 2025), 0.01% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.